Page last updated: 2024-09-05

darunavir and chloramphenicol

darunavir has been researched along with chloramphenicol in 2 studies

Compound Research Comparison

Studies
(darunavir)
Trials
(darunavir)
Recent Studies (post-2010)
(darunavir)
Studies
(chloramphenicol)
Trials
(chloramphenicol)
Recent Studies (post-2010) (chloramphenicol)
1,14822478020,1133881,464

Protein Interaction Comparison

ProteinTaxonomydarunavir (IC50)chloramphenicol (IC50)
30S ribosomal protein S6Escherichia coli K-120.43
30S ribosomal protein S7Escherichia coli K-120.43
50S ribosomal protein L15Escherichia coli K-120.43
50S ribosomal protein L10Escherichia coli K-120.43
50S ribosomal protein L11Escherichia coli K-120.43
50S ribosomal protein L7/L12Escherichia coli K-120.43
50S ribosomal protein L19Escherichia coli K-120.43
50S ribosomal protein L1Escherichia coli K-120.43
50S ribosomal protein L20Escherichia coli K-120.43
50S ribosomal protein L27Escherichia coli K-120.43
50S ribosomal protein L28Escherichia coli K-120.43
50S ribosomal protein L29Escherichia coli K-120.43
50S ribosomal protein L31Escherichia coli K-120.43
50S ribosomal protein L31 type BEscherichia coli K-120.43
50S ribosomal protein L32Escherichia coli K-120.43
50S ribosomal protein L33Escherichia coli K-120.43
50S ribosomal protein L34Escherichia coli K-120.43
50S ribosomal protein L35Escherichia coli K-120.43
50S ribosomal protein L36Escherichia coli K-120.43
30S ribosomal protein S10Escherichia coli K-120.43
30S ribosomal protein S11Escherichia coli K-120.43
30S ribosomal protein S12Escherichia coli K-120.43
30S ribosomal protein S13Escherichia coli K-120.43
30S ribosomal protein S16Escherichia coli K-120.43
30S ribosomal protein S18Escherichia coli K-120.43
30S ribosomal protein S19Escherichia coli K-120.43
30S ribosomal protein S20Escherichia coli K-120.43
30S ribosomal protein S2Escherichia coli K-120.43
30S ribosomal protein S3Escherichia coli K-120.43
30S ribosomal protein S4Escherichia coli K-120.43
30S ribosomal protein S5Escherichia coli K-120.43
30S ribosomal protein S8Escherichia coli K-120.43
30S ribosomal protein S9Escherichia coli K-120.43
50S ribosomal protein L13Escherichia coli K-120.43
50S ribosomal protein L14Escherichia coli K-120.43
50S ribosomal protein L16Escherichia coli K-120.43
50S ribosomal protein L23Escherichia coli K-120.43
30S ribosomal protein S15Escherichia coli K-120.43
50S ribosomal protein L17Escherichia coli K-120.43
50S ribosomal protein L21Escherichia coli K-120.43
50S ribosomal protein L30Escherichia coli K-120.43
50S ribosomal protein L6Escherichia coli K-120.43
30S ribosomal protein S14Escherichia coli K-120.43
30S ribosomal protein S17Escherichia coli K-120.43
30S ribosomal protein S1Escherichia coli K-120.43
50S ribosomal protein L18Escherichia coli K-120.43
50S ribosomal protein L2Escherichia coli K-120.43
50S ribosomal protein L3Escherichia coli K-120.43
50S ribosomal protein L24Escherichia coli K-120.43
50S ribosomal protein L4Escherichia coli K-120.43
50S ribosomal protein L22Escherichia coli K-120.43
50S ribosomal protein L5Escherichia coli K-120.43
30S ribosomal protein S21Escherichia coli K-120.43
50S ribosomal protein L25Escherichia coli K-120.43
50S ribosomal protein L36 2Escherichia coli K-120.43

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Reviews

1 review(s) available for darunavir and chloramphenicol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for darunavir and chloramphenicol

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023